Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...

Updated data from the BEXMAB study reveals a significant increase in complete remission rates for patients with high-risk ...

Leukemia, also known as Blood Cancer is a malignancy that affects the blood and bone marrow, leading to a rapid overproduction of abnormal white blood cells. These abnormal cells disrupt the bone ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from cancer.

However, its specific role and molecular mechanisms in acute myeloid leukemia (AML) remain largely unexplored. Methods: To identify key genes associated with AML, we analyzed gene expression profiles ...

1 Introduction Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by uncontrolled clonal proliferation of immature myeloid cells, resulting in the accumulation of ...